Series B funding round for Affinia Therapeutics raising $110M in May 2021
Series B funding round for Affinia Therapeutics raising $110M in May 2021
| Investor | Firm Type | Partner |
|---|
EcoR1 CapitalLEAD | Hedge Fund | — |
| Hedge Fund | — | |
| Private | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$210M
Top Valuation
-
Affinia Therapeutics raised $110M in a Series B round.
The round was announced on 05/01/21.
The round was led by Caroline Stout, Farallon Capital Management.